Isabelle Portal

TL;DR: Treatment with direct-acting antivirals is associated with reduced risk for mortality and hepatocellular carcinoma and should be considered in all patients with chronic HCV infection.

TL;DR: The Compassionate Use of Protease Inhibitors in Viral C Cirrhosis (COCIR) study as mentioned in this paper investigated the effectiveness of the protease inhibitors peginterferon and ribavirin in treatment-experienced patients with hepatitis C virus (HCV) genotype 1 infection and cirrhosis.

TL;DR: This prospective independent and multicenter study confirms the diagnostic value ofFT and AT found in the princeps study and suggests that FT and AT can be an alternative to biopsy in most patients with chronic HCV.

TL;DR: It was shown that serum hyaluronic acid (HA) level increases with the development for liver fibrosis, and accurate HA level cut-offs were defined for predicting significant fibrosis and/or cirrhosis.

TL;DR: A changing pattern of HCV genotypes in France is shown, with i.v. drug abuse as the major risk factor, an increase of genotype 4, and to a lesser extent 1a and 5, and a decrease of genotypes 1b and 2.